Conjunctival pyogenic granuloma associated with intravitreal bevacizumab injection

Oded Sagiv*, Ilia Piven, Mordechai Rosner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To report a case of conjunctival pyogenic granuloma after intravitreal injection of anti-vascular endothelial growth factor, bevacizumab. Methods: A 52-year-old patient after 3 intravitreal bevacizumab injections was found to have a vascular conjunctival nodule at the injection site. A pathologic analysis of the vascular conjunctival nodule was performed after surgical excision. Results: The pathologic analysis revealed a conjunctival pyogenic granuloma. Conclusion: Conjunctival pyogenic granuloma can complicate an otherwise uneventful intravitreal anti-vascular endothelial growth factor injection.

Original languageEnglish
Pages (from-to)291-293
Number of pages3
JournalRetinal Cases and Brief Reports
Volume7
Issue number3
DOIs
StatePublished - Jun 2013
Externally publishedYes

Keywords

  • Anti-vascular endothelial growth factor
  • Bevacizumab
  • Conjunctival vascular tumors
  • Intravitreal injection
  • Pyogenic granuloma

Fingerprint

Dive into the research topics of 'Conjunctival pyogenic granuloma associated with intravitreal bevacizumab injection'. Together they form a unique fingerprint.

Cite this